← All trials
NCT05881980
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 31, 2023
- Primary completion
- Oct 31, 2023
- Completion date
- Nov 30, 2023
- First posted
- May 31, 2023
- Last posted
- May 31, 2023
- Enrollment
- 150
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Dhaka Medical CollegeLead sponsor
- Dhaka Medical CollegeReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.